The main outcome of this project is MaxLynx, a new crosslinking workflow integrated into MaxQuant (Cox, et al., 2008). Now any MaxQuant user can identify their XLMS spectra. To address this, Andromeda peptide database search engine (Cox, et al., 2011) was generalized to efficiently identify cross-linked peptides. In a typical MaxQuant workflow, after Andromeda score calculation, posterior error probabilities (PEP) are computed to control false-discovery rated (FDR). Here, PEPs are adapted for crosslinked peptides with introducing new parameters such as using partial scores summarize the evidence for the two constituents of the di-peptide individually. The three-dimensional peak detection of MaxQuant was improved to obtain more accurate determination of the monoisotopic peak of isotope patterns for heavy molecules, such as typical cross-linked peptides. A wide selection of filtering parameters is available which can replace manual filtering of identifications. On benchmark datasets of synthetic peptides, MaxLynx outperformed all other tested software on data for both types of crosslinkers as well as on a proteome-wide dataset of cross-linked D. melanogaster cell lysate (Yılmaz, et al., 2022). The MaxLynx workflow also supports a new MS technology, trapped-ion-mobility mass spectrometry. I presented the details of MaxLynx at the annual MaxQuant Summer School and MaxLynx has been recently published (Yılmaz, et al., 2022).